Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
BMC Neurology|February 15, 2007
Neuroacanthocytosis associated with a defect of the 4.1R membrane proteinAntonio Orlacchio, Paolo Calabresi, Adriana Rum, et al.Haematologica|September 12, 2006
Risk factors for death in patients with beta-thalassemia major: results of a case-control studyAdriana Ceci, Paola Baiardi, Mariana Catapano, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 12, 2008
Guideline recommendations for heart complications in thalassemia majorTiziana Cogliandro, Giorgio Derchi, Luigi Mancuso, et al.Blood Cells, Molecules & Diseases|August 4, 2010
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine aloneMaria Eliana Lai, Robert W Grady, Stefania Vacquer, et al.Blood Transfusion = Trasfusione Del Sangue|June 3, 2014
Antibodies reacting with Simian virus 40 mimotopes in serum samples from patients with thalassaemia majorCaterina Borgna-Pignatti, Elisa Mazzoni, Marcella Felletti, et al.Magnetic Resonance Imaging|August 1, 2008
Improved T2* assessment in liver iron overload by magnetic resonance imagingVincenzo Positano, Benedetta Salani, Alessia Pepe, et al.Haematologica|October 13, 2004
Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 casesDaniele Prati, Marco Maggioni, Silvano Milani, et al.British Journal of Haematology|December 17, 2003
Hepatocellular carcinoma in the thalassaemia syndromesCaterina Borgna-Pignatti, Gianluca Vergine, Turi Lombardo, et al.Haematologica|January 2, 2008
Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expressionEmilie Camberlein, Giuliana Zanninelli, Lénaïck Détivaud, et al.Current Medical Research and Opinion|May 30, 2008
Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA studyLuciana Scalone, Lorenzo G Mantovani, Marieke Krol, et al.Pageof 5